Skip to main content
Top
Published in: Virology Journal 1/2020

Open Access 01-12-2020 | Kidney Transplantation | Research

Incidence and risk factors for high-level BK viruria: a single center study in China

Authors: Rui Xiong, Haimin Ye, Zhujing Liu, Xinchang Li

Published in: Virology Journal | Issue 1/2020

Login to get access

Abstract

Background

BK virus allograft nephropathy is a serious complication after kidney transplantation, and the effect of pre-emptive intervention for high-level BK viruria has been verified, but protocols after kidney transplantation for early identification of high-level viruria are lacking.

Methods

This was a single-center study. The clinical data of the kidney transplant recipients and their donors in our center from January 1, 2015 to December 31, 2018, were collected. The patients were divided into the high-level BK viruria group (Group A) and a non-high-level BK viruria group (Group B) according to the qPCR results of BK virus DNA loads in urine samples. Significant variables were screened out by univariate analysis, and then the results were incorporated into a multivariate logistic regression model to analyze the independent risk factors for high-level BK viruria.

Results

A total of 262 recipients were included in the study. The incidence of high-level BK viruria was 13.4% (n = 35), and the median time of detection was 181 (range 91–1119) days. Univariate analysis showed that donor type (\(\chi^{2}\) = 21.770, P < 0.001), history of ATG/ATG-F application (\(\chi^{2}\) = 4.543, P = 0.033), acute rejection (AR) (\(\chi^{2}\) = 8.313, P = 0.004) and delayed graft function (DGF) (\(\chi^{2}\) = 21.170, P < 0.001) were related to high-level BK viruria. After the inclusion of the multivariate logistic regression model, the results showed deceased brain and cardiac donors (P = 0.032, OR = 3.927, 95% CI 1.122–13.746), AR (P = 0.022, OR = 4.709, 95% CI 1.253–17.697) and DGF (P = 0.001, OR = 6.682, 95% CI 2.288–19.518).

Conclusions

Donation by deceased brain and cardiac patients, history of AR and DGF were independent risk factors for high-level BK viruria after kidney transplantation.
Literature
2.
go back to reference Broeders EN, Hamade A, El Mountahi F, Racapé J, Hougardy JM, Le Moine A, et al. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function. Transplant Infect Dis. 2016;18(6):872–80. CrossRef Broeders EN, Hamade A, El Mountahi F, Racapé J, Hougardy JM, Le Moine A, et al. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function. Transplant Infect Dis. 2016;18(6):872–80. CrossRef
3.
go back to reference Yuan X, Chen C, Zheng Y, Wang C. Conversion From mycophenolates to mizoribine is associated with lower BK virus load in kidney transplant recipients: a prospective study. Transplant Proc. 2018;50(10):3356–60. CrossRef Yuan X, Chen C, Zheng Y, Wang C. Conversion From mycophenolates to mizoribine is associated with lower BK virus load in kidney transplant recipients: a prospective study. Transplant Proc. 2018;50(10):3356–60. CrossRef
4.
go back to reference Funahashi Y, Hattori R, Kinukawa T, Kimura H, Nishiyama Y, Gotoh M. Conversion from mycophenolate mofetil to mizoribine for patients with positive polyomavirus type BK in urine. Transplant Proc. 2008;40(7):2268–70. CrossRef Funahashi Y, Hattori R, Kinukawa T, Kimura H, Nishiyama Y, Gotoh M. Conversion from mycophenolate mofetil to mizoribine for patients with positive polyomavirus type BK in urine. Transplant Proc. 2008;40(7):2268–70. CrossRef
5.
go back to reference Hirsch HH, Randhawa PS. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13528. CrossRef Hirsch HH, Randhawa PS. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13528. CrossRef
6.
go back to reference Randhawa P, Ho A, Shapiro R, Vats A, Swalsky P, Finkelstein S, et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol. 2004;42(3):1176–80. CrossRef Randhawa P, Ho A, Shapiro R, Vats A, Swalsky P, Finkelstein S, et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol. 2004;42(3):1176–80. CrossRef
8.
go back to reference Antonsson A, Green AC, Mallitt KA, O’Rourke PK, Pawlita M, Waterboer T, et al. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J Gen Virol. 2010;91:1849–53. CrossRef Antonsson A, Green AC, Mallitt KA, O’Rourke PK, Pawlita M, Waterboer T, et al. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J Gen Virol. 2010;91:1849–53. CrossRef
9.
go back to reference Gossai A, Waterboer T, Nelson HH, Michel A, Willhauck-Fleckenstein M, Farzan SF, et al. Seroepidemiology of human polyomaviruses in a US population. Am J Epidemiol. 2016;183(1):61–9. CrossRef Gossai A, Waterboer T, Nelson HH, Michel A, Willhauck-Fleckenstein M, Farzan SF, et al. Seroepidemiology of human polyomaviruses in a US population. Am J Epidemiol. 2016;183(1):61–9. CrossRef
10.
go back to reference Dalianis T, Eriksson BM, Felldin M, Friman V, Hammarin AL, Herthelius M, et al. Management of BK-virus infection—Swedish recommendations. Infect Dis. 2019;51(7):479–84. CrossRef Dalianis T, Eriksson BM, Felldin M, Friman V, Hammarin AL, Herthelius M, et al. Management of BK-virus infection—Swedish recommendations. Infect Dis. 2019;51(7):479–84. CrossRef
11.
go back to reference Reischig T, Kacer M, Hes O, Machova J, Nemcova J, Kormunda S, et al. Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies. Nephrol Dial Transplant. 2019;34(11):1970–8. PubMed Reischig T, Kacer M, Hes O, Machova J, Nemcova J, Kormunda S, et al. Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies. Nephrol Dial Transplant. 2019;34(11):1970–8. PubMed
12.
go back to reference Hsieh MC, Hung CW, Chiou HL, Yang SF. Effect of a BK viruria reaction detected by qualitative polymerase chain reaction on the renal function of kidney transplant recipients. Mol Med Rep. 2013;7(4):1319–23. CrossRef Hsieh MC, Hung CW, Chiou HL, Yang SF. Effect of a BK viruria reaction detected by qualitative polymerase chain reaction on the renal function of kidney transplant recipients. Mol Med Rep. 2013;7(4):1319–23. CrossRef
13.
go back to reference Huang J, Millis JM, Mao Y, Millis MA, Sang X, Zhong S. A pilot programme of organ donation after cardiac death in China. Lancet. 2012;379(9818):862–5. CrossRef Huang J, Millis JM, Mao Y, Millis MA, Sang X, Zhong S. A pilot programme of organ donation after cardiac death in China. Lancet. 2012;379(9818):862–5. CrossRef
14.
go back to reference Demey B, Tinez C, François C, Helle F, Choukroun G, Duverlie G, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review. J Clin Virol. 2018;109:6–12. CrossRef Demey B, Tinez C, François C, Helle F, Choukroun G, Duverlie G, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review. J Clin Virol. 2018;109:6–12. CrossRef
Metadata
Title
Incidence and risk factors for high-level BK viruria: a single center study in China
Authors
Rui Xiong
Haimin Ye
Zhujing Liu
Xinchang Li
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2020
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-020-01460-5

Other articles of this Issue 1/2020

Virology Journal 1/2020 Go to the issue